Abstract:Abstract Background Chemoresistance is a major obstacle that limits the benefits of 5-Fluorouracil (5-Fu)-based chemotherapy for colon cancer patients. Autophagy is an important cellular mechanism underlying chemoresistance. Recent research advances have given new insights into the use of natural bioactive compounds to overcome chemoresistance in colon cancer chemotherapy. As one of the multitargeted and safer phytomedicines, curcumin has been reported to work as cancer-specific chemosensitizer, presumably via induction of autophagic signaling pathways. The precise therapeutic effect of curcumin on autophagy in determining tumorous cells’ fate, however, remains unclear. This study was conducted to investigate the differential modulations of the treatments either with 5-Fu alone or 5-Fu combined with curcumin on cellular autophagic responses and viabilities in the human colon cancer cells HCT116 and HT29, and explore molecular signaling transductions underlying the curcumin-mediated autophagic changes and potentiation of 5-Fu’s cytotoxicity in vitro and in vivo. Methods Cell proliferation assay and morphology observation were used to identify the cytotoxicity of different combinations of curcumin and 5-Fu in HCT116 and HT29 cells. Cell immunofluorescence assay, Flow cytometry and Western blot were employed to detect changes of autophagy and the autophagy-related signaling pathways in the colon cancer cells and/or xenograft mice. Results Curcumin could significantly augment the cytotoxicity of 5-Fu to the tumorous cells, and the pre-treatment with curcumin followed by 5-Fu (pre-Cur) proved to be the most effective one compared to other two combinations. The chemosensitizing role of curcumin might attribute to the autophagy turnover from being activated in 5-Fu mono-treatment to being inhibited in the pre-Cur treatment as indicated by the changes in expression of beclin-1, p62 and LC3II/LC3I and the intensity of Cyto-ID Green staining. The autophagic alterations appeared to be contributed by down-regulation of not only the phospho-Akt and phospho-mTOR expressions but the phospho-AMPK and phospho-ULK1 levels as well. The cellular activation of AMPK by addition of A-769662 to the pre-Cur combination resulted in reversed changes in expressions of the autophagy protein markers and apoptotic status compared to those of the pre-Cur combination treatment. The findings were validated in the xenograft mice, in which the tumor growth was significantly suppressed in the mice with 25-day combination treatment, and meanwhile expressions of the autophagy markers, P-AMPK and P-ULK1 were all reversely altered in line with those observed in HCT116 cells. Conclusion Pre-treatment with curcumin followed by 5-Fu may mediate autophagy turnover both in vitro and in vivo via AMPK/ULK1-dependent autophagy inhibition and AKT modulation, which may account for the increased susceptibility of the colon cancer cells/xenograft to the cytotoxicity of 5-Fu.

Abrogation of G2/M Arrest Sensitizes Curcumin‐resistant Hepatoma Cells to Apoptosis

Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy.

Curcumin induces mitochondrial apoptosis in human hepatoma cells through BCLAF1-mediated modulation of PI3K/AKT/GSK-3β signaling

Curcumin Induces Apoptosis in Human Lung Adenocarcinoma A549 Cells Through a Reactive Oxygen Species-Dependent Mitochondrial Signaling Pathway.

Curcumin Induces Mitochondria Pathway Mediated Cell Apoptosis in A549 Lung Adenocarcinoma Cells.

Curcumin Induces Apoptosis Through the Mitochondria-Mediated Apoptotic Pathway in HT-29 Cells

Curcumin Reverses Chemoresistance of Human Gastric Cancer Cells by Downregulating the NF-κB Transcription Factor

Curcumin Induces Apoptosis in Gallbladder Carcinoma Cell Line GBC-SD Cells

Retracted: Notch‐1 Down‐regulation by Curcumin is Associated with the Inhibition of Cell Growth and the Induction of Apoptosis in Pancreatic Cancer Cells

Curcumin Enhances the Antitumor Effect of Abt-737 Via Activation of the Ros-Ask1-Jnk Pathway in Hepatocellular Carcinoma Cells

Curcumin induces G2/M arrest and triggers autophagy, ROS generation and cell senescence in cervical cancer cells

Curcumin Induces Apoptosis in EJ Bladder Cancer Cells Via Modulating C-Myc and PI3K/Akt Signaling Pathway

Curcumin induces apoptosis through mitochondrial hyperpolarization and mtDNA damage in human hepatoma G2 cells.

Curcumin Induces G2/M Cell Cycle Arrest and Apoptosis of Head and Neck Squamous Cell Carcinoma in Vitro and in Vivo Through Atm/Chk2/P53-Dependent Pathway

Curcumin Induces Apoptosis in Human Non-Small Cell Lung Cancer NCI-H460 Cells Through ER Stress and Caspase Cascade- and Mitochondria-Dependent Pathways.

Curcumin metabolites induce autophagic cell death through PI3K/AKT‐mTOR signaling in COLO205 human colon adenocarcinoma cells

RETRACTED ARTICLE: Curcumin Synergizes with 5-Fluorouracil by Impairing AMPK/ULK1-dependent Autophagy, AKT Activity and Enhancing Apoptosis in Colon Cancer Cells with Tumor Growth Inhibition in Xenograft Mice

Apoptosis Induced by Curcumin Through Peroxisome Proliferator Activated Receptor-Γ Signaling Pathway in Human Renal Cell Carcinoma

Curcumin induces Apoptosis via PTEN/PI3K/Akt pathway in human bladder careinoma EJ cells

Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression

Reverse Effect of Curcumin on CDDP-induced Drug-Resistance Via Keap1/p62-Nrf2 Signaling in A549/CDDP Cell.